Fate Therapeutics Inc (FATE) Sof foyda bo'yicha sotuv rentabelligi

Fate Therapeutics, Inc. (FATE) tovar belgisi

GURU.Markets grafigidagi savdo marjasi darajasi, u yerda -2619.60 indikatori metrika holatini ifodalaydi, kapital boshqaruvining shaffofligini va Fate Therapeutics, Inc. (FATE) rahbariyatining yuqori ilmiy malakasini tasdiqlaydi. Tendentsiya klinik sinovlar natijalariga bog'liq, tashqi R&D moliyalashtirishi esa sherikliklar orqali muvozanatga keltirilgan. Fate Therapeutics, Inc. (FATE) ommaviy onkologik davolash uchun kengaytiriladigan hujayraviy mahsulotlarni yaratib, hamyonbop iPSC immunoterapiyasini joriy qilmoqda.

FATE: Fate Pharma Kompaniyaning sof rentabelligi 04.07.2022 - 20.11.2026

Fate Therapeutics, Inc. kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning jamlanma tahliliyoti:fatetherapeutics.com - FATE
Fate Therapeutics Corp yetakchi tovari

Fate Therapeutics, Inc. (FATE) ning stam hujayralar platformasining kengaytiriluvchanligi dori ishlab chiqarish xarajatlarini kamaytirish imkonini beradi, bu esa sof foyda marjasiga bevosita ta'sir qiladi. Ushbu ko'rsatkich barcha xarajatlar chegirib tashlanganidan keyin har bir dollar daromadning qancha qismi foyda ekanligini o'lchaydi, bu esa investorlarga kapital boshqaruvining operatsion samaradorligini baholash va aktivning haqiqiy investitsiya jozibadorligini aniqlash imkonini beradi.

Raqobatchilar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)